Key facts
- This page summarizes Michael L. Peterson's Form 4 filing for TRxADE HEALTH, INC (SCNX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Jan 2023, 15:15.
Michael L. Peterson - 16 Jan 2023 Form 4 Insider Report for TRxADE HEALTH, INC (SCNX)
- Reporting relationship
- Director
- Issuer ticker
- SCNX
- Reported as of
- 16 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Jan 2023, 15:15:19 UTC
- Prior SEC filing
- 06 Jan 2023
- Next SEC filing
- 17 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael L. Peterson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael L. Peterson filed Form 4 for TRxADE HEALTH, INC (SCNX) on 20 Jan 2023.
Change
- Previous filing in this sequence was filed on 06 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MEDS
transaction
Common stock
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- +528%
- Price
- $0.000000
- Shares after
- 118,940
- Date
- 16 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MEDS
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +135,802
- Change %
- Price
- $0.000000
- Shares after
- 135,802
- Date
- 16 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 135,802
- Exercise price
- $0.4050
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/8th of such shares per quarter (on the first day of each calendar quarter), with the first vesting beginning on April 1, 2023, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.
Footnote F2
Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer and Chairperson of the Audit Committee. Issued under the Issuer's Amended and Restated 2019 Equity Incentive Plan.
Footnote F3
The options vest at the rate of 1/2 of such options per year, on January 4, 2024 and 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3.